Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumors
- 31 January 2004
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 70 (1) , 91-97
- https://doi.org/10.1016/j.radonc.2003.09.012
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- 3-Substituted-5-aziridinyl-1-methylindole-4,7-diones as NQO1-directed antitumour agents: mechanism of activation and cytotoxicity in vitroBiochemical Pharmacology, 2003
- HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumorsInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomasBritish Journal of Cancer, 2000
- Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assaysInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liverBritish Journal of Cancer, 1995
- Relationship between the melanin content of a human melanoma cell line and its radiosensitivity and uptake of pimonidazoleCancer Chemotherapy and Pharmacology, 1993
- Retention of misonidazole in normal and malignant tissues: Interplay of hypoxia and reductasesInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cellsBritish Journal of Cancer, 1992
- Tissue distribution of 14C- and 3H-labelled misonidazole in the tumor-bearing mouseInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The labelling of EMT-6 tumours in BALB/C mice with14C-misonidazoleThe British Journal of Radiology, 1983